AIM: To describe the in vivo spatial and morphological vitreoretinal relationships associated with diabetic retinal neovascularisation using Fourier-domain optical coherence tomography (FD-OCT). METHODS: Qualitative assessment of macula, retina and optic disc head FD-OCT (Topcon 3D OCT-1000) imaging of patients with treatment-naive and laser-treated proliferative diabetic retinopathy (PDR). The morphology and plane of retinal neovascularisation at the disc (NVD) and elsewhere in the retina (NVE) were examined, and the posterior vitreous relationships were evaluated. The FD-OCT characteristics of clinical versus subclinical PDR disease were correlated with conventional and wide-field Optos fundus fluorescein angiography. RESULTS: 50 eyes of 50 patients were evaluated in this retrospective study. Retinal neovascularisation appears as a hyper-reflective complex, with NVE arising from inner retina with disruption through the internal limiting membrane to attach to the posterior hyaloid surface. FD-OCT detected subclinical hyper-reflective NVD complexes that were subvisible on colour fundus imaging. We describe retinoschisis, vitreoretinal adhesions and pegs, zones of separation, and intraretinal tractional elements in untreated PDR patients using high resolution FD-OCT. CONCLUSIONS: FD-OCT can non-invasively characterise retinal and optic nerve head neovascular complexes at different stages of the proliferative disease process. In clinical practice, FD-OCT can monitor the in vivo serial changes of retinal neovascularisation over time.
AIM: To describe the in vivo spatial and morphological vitreoretinal relationships associated with diabetic retinal neovascularisation using Fourier-domain optical coherence tomography (FD-OCT). METHODS: Qualitative assessment of macula, retina and optic disc head FD-OCT (Topcon 3D OCT-1000) imaging of patients with treatment-naive and laser-treated proliferative diabetic retinopathy (PDR). The morphology and plane of retinal neovascularisation at the disc (NVD) and elsewhere in the retina (NVE) were examined, and the posterior vitreous relationships were evaluated. The FD-OCT characteristics of clinical versus subclinical PDR disease were correlated with conventional and wide-field Optos fundus fluorescein angiography. RESULTS: 50 eyes of 50 patients were evaluated in this retrospective study. Retinal neovascularisation appears as a hyper-reflective complex, with NVE arising from inner retina with disruption through the internal limiting membrane to attach to the posterior hyaloid surface. FD-OCT detected subclinical hyper-reflective NVD complexes that were subvisible on colour fundus imaging. We describe retinoschisis, vitreoretinal adhesions and pegs, zones of separation, and intraretinal tractional elements in untreated PDR patients using high resolution FD-OCT. CONCLUSIONS: FD-OCT can non-invasively characterise retinal and optic nerve head neovascular complexes at different stages of the proliferative disease process. In clinical practice, FD-OCT can monitor the in vivo serial changes of retinal neovascularisation over time.
Authors: Francesco Pichi; Scott D Smith; Emad B Abboud; Piergiorgio Neri; Elizabeth Woodstock; Steven Hay; Emily Levine; Caroline R Baumal Journal: Graefes Arch Clin Exp Ophthalmol Date: 2020-05-30 Impact factor: 3.117
Authors: Cecilia S Lee; Aaron Y Lee; Dawn A Sim; Pearse A Keane; Hemal Mehta; Javier Zarranz-Ventura; Marcus Fruttiger; Catherine A Egan; Adnan Tufail Journal: Am J Ophthalmol Date: 2014-10-25 Impact factor: 5.258
Authors: Qinqin Zhang; Cecilia S Lee; Jennifer Chao; Chieh-Li Chen; Thomas Zhang; Utkarsh Sharma; Anqi Zhang; Jin Liu; Kasra Rezaei; Kathryn L Pepple; Richard Munsen; James Kinyoun; Murray Johnstone; Russell N Van Gelder; Ruikang K Wang Journal: Sci Rep Date: 2016-02-25 Impact factor: 4.379
Authors: Sonja G Karst; Jan Lammer; Salma H Radwan; Hanna Kwak; Paolo S Silva; Stephen A Burns; Lloyd Paul Aiello; Jennifer K Sun Journal: Int J Endocrinol Date: 2018-05-02 Impact factor: 3.257
Authors: Luke Nicholson; Chrishne Sivapathasuntharam; Marta Zola; Philip Hykin; James W Bainbridge; Sobha Sivaprasad Journal: JAMA Ophthalmol Date: 2017-09-01 Impact factor: 7.389